Literature DB >> 1270086

Subfragmentation of the Fc fragment of human IgG1 myeloma protein by thermolysin.

I M Hunneyball, D R Stanworth.   

Abstract

Human IgG1 Fc fragment was digested at neutral pH by thermolysin, producing two large subfragments: one comprising the major part of the Fc fragment but devoid of the hinge region; the other comprising the Cgamma3 domain. The former fragment retained the capacity to react with "general" rheumatoid factors whereas the latter did not, indicating that the binding site for "general" rheumatoid factors on the Fc fragment of human IgG1 does not involve the hinge region of the molecule.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1270086      PMCID: PMC1445030     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  Structural units of human 7S gamma globulin.

Authors:  E C FRANKLIN
Journal:  J Clin Invest       Date:  1960-12       Impact factor: 14.808

2.  Reaction of rheumatoid sera with fragments of papain-digested rabbit gamma globulin.

Authors:  J W GOODMAN
Journal:  Proc Soc Exp Biol Med       Date:  1961-04

3.  Spinach ferredoxin. II. Typtic, chymotryptic, and thermolytic peptides, and complete amino acid sequence.

Authors:  H Matsubara; R M Sasaki
Journal:  J Biol Chem       Date:  1968-04-25       Impact factor: 5.157

4.  The use of thermolysin in amino acid sequence determination.

Authors:  R P Ambler; R J Meadway
Journal:  Biochem J       Date:  1968-08       Impact factor: 3.857

5.  The recombination of dimers of immunoglobulin peptide chains.

Authors:  G T Stevenson; K J Dorrington
Journal:  Biochem J       Date:  1970-08       Impact factor: 3.857

6.  Conformation changes and dissociation of Fc fragments of rabbit immunoglobulin G as a function of pH.

Authors:  P A Charlwood; S Utsumi
Journal:  Biochem J       Date:  1969-04       Impact factor: 3.857

7.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

8.  The covalent structure of an entire gammaG immunoglobulin molecule.

Authors:  G M Edelman; B A Cunningham; W E Gall; P D Gottlieb; U Rutishauser; M J Waxdal
Journal:  Proc Natl Acad Sci U S A       Date:  1969-05       Impact factor: 11.205

9.  Specific nature of hydrolysis of insulin and tobacco mosaic virus protein by thermolysin.

Authors:  H Matsubara; R Sasaki; A Singer; T H Jukes
Journal:  Arch Biochem Biophys       Date:  1966-08       Impact factor: 4.013

10.  Fragmentation of human IgG by a new protease isolated from the basidiomycete Armillaria mellea.

Authors:  I M Hunneyball; D R Stanworth
Journal:  Immunology       Date:  1975-11       Impact factor: 7.397

View more
  5 in total

1.  The specificity of human autoantibodies to IgG: the development of methodology for measuring the specificity of antiglobulin isotypes in rheumatoid and normal sera.

Authors:  R E March; V R Winrow; E J Holborow
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

2.  Leucocyte migration inhibition with IgG-IgG complexes and rabbit IgG fragments in patients with rheumatoid arthritis.

Authors:  N D Hall
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

3.  The localization of the binding site(s) on human IgG1 for the Fc receptors on homologous monocytes and heterologous mouse macrophages.

Authors:  A Ratcliffe; D R Stanworth
Journal:  Immunology       Date:  1983-09       Impact factor: 7.397

4.  Production of antibodies to host IgG after transfer of histocompatible cells primed to host allotype.

Authors:  S A Grace; C J Elson; C M Coeshott
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

5.  The common occurrence of internal image type anti-idiotypic antibodies in rabbits immunized with monoclonal and polyclonal human IgM rheumatoid factors.

Authors:  S Fong; T A Gilbertson; P P Chen; J G Karras; J H Vaughan; D A Carson
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.